Celgene Corp (NASDAQ:CELG)

120.71
Delayed Data
As of Mar 05
 +1.14 / +0.95%
Today’s Change
66.85
Today|||52-Week Range
125.45
+7.91%
Year-to-Date

Today’s Trading

Previous close119.57
Today’s open120.48
Day’s range119.76 - 121.76
Volume3,583,196
Average volume (3 months)5,636,476
Market cap$95.7B
Dividend yield--
Data as of 3:59pm ET, 03/05/2015

Growth & Valuation

Earnings growth (last year)+41.84%
Earnings growth (this year)+30.17%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+17.89%
P/E ratio50.5
Price/Sales11.75
Price/Book14.66

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie-3.41-5.66%
NVONovo Nordisk-0.21-0.45%
AZNAstraZeneca+0.39+0.58%
ACTActavis-0.44-0.15%
Data as of 4:06pm ET, 03/05/2015

Financials

Next reporting dateApril 23, 2015
EPS forecast (this quarter)$1.06
Annual revenue (last year)$7.6B
Annual profit (last year)$2.0B
Net profit margin26.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert J. Hugin
President &
Chief Operating Officer
Mark J. Alles
Corporate headquarters
Summit, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account